Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Alto Neuroscience, Inc. (ANRO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Alto Neuroscience, Inc. (ANRO), most recent 12 months reported: net loss $84.24M, free cash flow -$68.84M. Latest balance sheet on file: liquid cash $243.73M, total debt $18.65M, net cash $225.08M. From SEC filings. Others in Pharmaceutical Preparations: Amylyx Pharmaceuticals, Inc. · ANEBULO PHARMACEUTICALS, INC. · ANIXA BIOSCIENCES, INC. · ANNEXON, INC. · AN2 Therapeutics, Inc. · Annovis Bio, Inc. · Aprea Therapeutics, Inc. · APIMEDS PHARMACEUTICALS US, INC.

Stock screener

Watchlist